Cipher Pharma (CPHR) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. GOOGL
5. SPY
6. RMR
7. TSM
8. SPCX
9. DVN
10. CRGY

Go back to Cipher Pharma (CPHR) Tops Q4 EPS by 8c

Cipher Pharma (CPHR) Launches Actikerall in Canada

February 22, 2016 7:05 AM EST

Cipher Pharmaceuticals Inc. (NASDAQ: CPHR) announced the Canadian launch of Actikerall (0.5% fluorouracil and 10% salicylic acid), indicated for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp in immunocompetent adult patients1. Actinic keratosis, also known as solar keratosis, is a skin condition caused by exposure to ultraviolet radiation2. Cipher... More